CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-27 | Malecek Michael J See Remarks | Sale | −5,964 | $58.07 | $346K | 4,036 |
| 2021-10-27 | Malecek Michael J See Remarks | Sale | −2,950 | $58.88 | $174K | 1,086 |
| 2021-10-27 | Malecek Michael J See Remarks | Sale | −1,066 | $60.03 | $64K | 20 |
| 2021-10-27 | Malecek Michael J See Remarks | Sale | −20 | $60.89 | $1K | 0 |
| 2021-10-27 | Malecek Michael J See Remarks | Option exercise · Stock Option (Right to Buy) | −10,000 | 240,000 | ||
| 2021-10-20 | Walker Karin L Chief Accounting Officer | Option exercise | +20,000 | $15.04 | $301K | 20,000 |
| 2021-10-20 | Walker Karin L Chief Accounting Officer | Option exercise | +3,000 | $29.81 | $89K | 23,000 |
| 2021-10-20 | Walker Karin L Chief Accounting Officer | Sale | −19,115 | $60.00 | $1.1M | 3,885 |
| 2021-10-20 | Walker Karin L Chief Accounting Officer | Sale | −1,700 | $60.91 | $104K | 2,185 |
| 2021-10-20 | Walker Karin L Chief Accounting Officer | Sale | −2,185 | $61.94 | $135K | 0 |
| 2021-10-20 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (right to buy) | −20,000 | 90,000 | ||
| 2021-10-20 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (right to buy) | −3,000 | 0 | ||
| 2021-10-01 | Selkoe Dennis J. Director | Option exercise | +5,000 | $9.23 | $46K | 7,845 |
| 2021-10-01 | Selkoe Dennis J. Director | Sale | −1,757 | $66.35 | $117K | 6,088 |
| 2021-10-01 | Selkoe Dennis J. Director | Sale | −1,300 | $67.96 | $88K | 4,788 |
| 2021-10-01 | Selkoe Dennis J. Director | Sale | −1,237 | $68.74 | $85K | 3,551 |
| 2021-10-01 | Selkoe Dennis J. Director | Sale | −706 | $69.69 | $49K | 2,845 |
| 2021-10-01 | Selkoe Dennis J. Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 11,000 | ||
| 2021-10-01 | Karp Carol D. Chief Regulatory Officer | Option exercise | +10,000 | $15.04 | $150K | 10,000 |
| 2021-10-01 | Karp Carol D. Chief Regulatory Officer | Sale | −2,600 | $66.60 | $173K | 7,400 |
Page 30 of 41 · 819 trades